Proc. Nati. Acad. Sci. USA
Vol. 86, pp. 9803-9807, December 1989
Biochemistry


Cloning gene encoding yeast protein BTF1Y, substitute human TATA box-binding factor
     (transcription initiation vitro/RNA polymerase B/HeLa cells/initiation factors)
B. CAVALLINI,  FAUS, H. MATTHES, J. M. CHIPOULET, B. WINSOR, J. M. EGLY, P. CHAMBON*
Laboratoire Gdndtique Moldculaire des Eucaryotes du Centre National la Recherche Scientifique, Unite 184 Biologie Moleculaire et Genie
Gdndtique l'Institut National la Santd et la Recherche Mddicale, Institut Chimie Biologique, Facultd Mddecine, 67085 Strasbourg Cddex, France
Contributed P. Chambon, October 2, 1989

ABSTRACT          activity (designated BTF1Y) extracts                     cells (17, 18). study yeast TATA box-
Saccharomyces cerevisiae substitute human TATA                          binding factor BTF1Y df obvious  purified
box-binding factor BTF1 reconstituted transcription sys-                       protein cloned corresponding gene.t
tem containing adenovirus 2 major late promoter, RNA
polymerase B (II), basic transcription factors BTF2,                                    MATERIALS METHODS
BTF3, STF. purified BTF1Y homogeneity,
using assays reconstitution vitro transcription                           Purification BTF1Y Protein. S100 extract (34 mg DNase footprinting TATA element. activities                           protein ml) prepared frozen S. cerevisiae cells
copurified 27-kDa polypeptide determined                               described (19). overnight dialysis buffer DB
SDS/PAGE. Gel filtration indicated molecular mass 28 ±                         [10 mM Tris'HCl, pH 7.9/5 mM MgCl2/0.5 mM dithiothrei-
5 kDa nondenaturing conditions, suggesting                           tol/17.4  (vol/vol) glycerol/0.2 mM phenylmethanesulfonyl
native BTF1Y protein monomer. BTF1Y enzymatically                          fluoride (PMSF)] containing 0.05 M KCI, 125 ml 2-fold-
cleaved, peptides sequenced, appropriate                           diluted S100 loaded 450-tnl heparin-Ultrogel (IBF)
oligonucleotide probes synthesized clone BTF1Y                          column equilibrated buffer DB containing 0.1 M KCI. gene yeast genomic library. BTF1Y gene contains                          washing, proteins eluted stepwise buffer DB 720-base-pair open reading frame encoding protein                            containing 0.15 M KCI, 0.37 M KCI (HEPO.37 fraction), 27,003 Da. recombinant protein expressed HeLa cells                          0.6 M KCl. BTF1Y activity HEPO.37
exhibited chromatographic characteristics vitro                     fraction. dialysis buffer B (50 mM Tris-HCl, pH
transcriptional activity BTF1Y prepared yeast ex-                           7.9/8.7  glycerol/0.1 mM EDTA/0.5 mM dithiothreitol/0.1
tracts, confirming identity gene. Gene-disruption                        mM PMSF) containing 0.08 M KCI, 2 liters HEPO.37
experiments indicated yeast BTF1Y gene single-                        fraction loaded 500-mI DEAE-Sephacel column.
copy essential gene.                                                                flow fraction (DEFT80), contained                                                                                     BTF1Y activity, 50 mM potassium phosphate (pH
Accurate specific initiation transcription vitro                     6.3) loaded sulfopropyl-5PW (Toyo Soda, Tokyo)
minimal promoter elements protein-coding genes requires                          HPLC column equilibrated buffer. Proteins transcription factors addition RNA poly-                        eluted linear 0.08-0.60 M KCl gradient. Active BTF1Y
merase B (II) (1-5). step transcription initiation                     fractions, eluted 0.4-0.5 M KCl (SPO.4 fraction),
corresponds binding factor BTF1  TATA                             dialyzed buffer B  PMSF) containing
box-binding factor, known TFIID DB)                              0.05 M KCl, 25 ml loaded heparin-5PW (Toyo
TATA box element (6-8). binding step crucial                         Soda) HPLC column. Proteins eluted linear
initiation pathway, results formation stable                   0.05-0.60 M KCI gradient, BTF1Y activity recovered "committed" complex factors RNA                             -0.5 M KCl (HEPO.5 fraction). milliliters polymerase B assemble form multiprotein complex                         HEPO.5 fraction dialyzed buffer C (50 mM
promoter proximal site (3, 4, 9-11).                                                Tris-HCl, pH 7.9/17.4  glycerol/0.1 mM EDTA/0.5 mM
   numerous attempts purify                              dithiothreitol/5 mM MgCI2) containing 0..1 M KCl loaded
mammalian BTF1, notably human HeLa cell extracts,                              400 /ul/heparin-Ultrogel column, equilibrated purification partial (e.g., ref. 8; unpublished                        buffer. Proteins eluted 50 mM steps 0.1
results).  recent studies shown yeast                             0.6 M KCI buffer C. Active BTF1Y fractions  Fig.
trans-activators stimulate transcription mammalian                           1B) dialyzed buffer C  MgC12) cells (12, 13)  conversely, mammalian regulatory                           loaded G-3000-SW (Toyo Soda) HPLC column factors (e.g., estrogen receptor) function yeast                         equilibrated  buffer B containing 0.3 M KCI 0. 1 
(14-16.) results indicated surprising evolutionary                          Brij-58 calibrated Pharmacia calibration kit.
conservation function yeast man, demonstrating                           BTF1Y activity recovered 30-kDa region trans-activators interact productively basic                      elution profile.
transcriptional machinery widely distant species.                              BTF1Y Protein Sequencing. Aliquots HEPO.5 fractions
conclusion supported demonstration                          concentrated using Speedvac microcentrifuge (Sa- yeast Saccharomyces cerevisiae contains activity                             vant) electrophoresed SDS/14  polyacrylamide
(BTF1Y) complement vitro HeLa cell-based                             gel. Proteins transferred poly(vinylidene
transcription lacking human BTF1 factor                              difluoride) membrane (Immobilon, Millipore) stained   participates formation functional
initiation complex basal factors mammalian
                                                                                    Abbreviations: Ad2MLP, adenovirus type 2 major late promoter;
                                                                                    ORF, open reading frame. publication costs article defrayed page charge           reprint requests addressed.
payment. article marked "advertisement"               tThe sequence reported paper deposited accordance 18 U.S.C. §1734 solely indicate fact.                     GenBank data base (accession  M29459).
                                                                             9803
 9804     Biochemistry: Cavallini et al.                                       Proc. Natl. Acad. Sci. USA 86     (1989) Ponceau S (20, 21). region membrane              cloned EcoRI site pTZ19U. Xba site present
containing 27-kDa polypeptide (-100 pmol) excised        pTZ19U polylinker destroyed 1.17-kb treated 1.25 ,Ag endo-proteinase lysine-C (Wako      HindIII-HindIII fragment containing yeast URA3 gene
Biochemicals, Osaka) 24 hr 25TC 25 mM Tris-HCI, pH     pFL1 (22) inserted blunt-end ligation 9.3/10 mM EDTA/0.1  hydrogenated Triton X-100/10                 Xba site located BTF1Y ORF, creating pDIS
acetonitrile. Peptides separated reverse-phase           (Fig. 4A). pDIS cleaved EcoRI used transform
HPLC (Brownlee Aquapore RP300, 7gm; 1 x 25 mm column;            yeast diploid strains, Aura3 trp 1-4 (constructed F.
gradient elution 10-60  acetonitrile 0.1  trifluoro-     Lacroute, Centre National la Recherche Scientifique,
acetic acid 120 min; flow rate 0.05 ml/min). peptides   Gif-sur-Yvette, France) YNN290 (25). Ura' colonies
(underlined Fig. 2A) sequenced Applied           selected structure transformants Biosystems model 477A protein sequencer.                         checked Southern blotting. positive clones   Cloning Sequencing Yeast BTF1Y Gene.            induced sporulate dissected tetrads grown degenerate oligodeoxynucleotide probes  B)            rich medium (YPED). Ura phenotype growing clones
synthesized based amino acid sequences peptides 1      determined replica plating minimal medium 2 (amino acids 219-228 84-95, respectively, Fig.      (YNB) uracil.
2A): probe  5'-AA C)G G)GAAGAAAT(T C)TA(T C)CAAGC(T TT(T C)GAA-3'; probe B,                                       RESULTS
5'-GTTGCT(T C)T(G CATGCT(C G G)AATGCTGAATA(T C)AAT-3'. yeast genomic DNA                    Purification ofBTF1Y. BTF1Y activity monitored library, constructed ligation partial Sau3A digest    DNase footprinting adenovirus 2 major late
FL100 DNA [average fragment size, 2.5 kilobases (kb)]       promoter (Ad2MLP) TATA element vitro tran- single BamHI site plasmid pFL1 (22), screened      scription template containing Ad2MLP (pM34,
hybridization nitrocellulose filters 32P-end-       309-nucleotide run transcript; ref. 26) reconsti-
labeled probes B 0.9 M NaCl/0.09 M sodium citrate,      tuted HeLa cell-based transcription lacking BTF1
pH 7/0.02  Ficoll/0.02  polyvinylpyrrolidone/0.02  bo-           (17). shown protein profile BTF1Y fractions
vine serum albumin/0.05  sodium pyrophosphate/0.1                chromatographic steps (Fig. 1A), heparin-5PW
SDS containing denatured salmon sperm DNA 100 ,g/ml.          HPLC followed concentration-rechromatography final washes 0.9 M NaCI/0.09 M sodium citrate,       active fractions heparin-Ultrogel resulted remarkable
pH 7/0.05  sodium pyrophosphate 72°C (probe          purification. run transcription activity (Fig. 1B  67°C (probe B). rounds screening,       footprinting activity Ad2MLP TATA box
clones hybridized probes isolated.         (Fig. 1B Lower, -21 -31 protection) coeluted independent clones insert sizes 4.6 kb (pL1) 3.8     heparin-Ultrogel column, pooled active fractions
kb (pL2) analyzed. Sma Sal fragments        contained single major polypeptide -27 kDa (Fig. lA, pL1 pL2 containing genomic inserts sub-          lane 7). protein corresponded BTF1Y cloned Sma Sal sites pTZ18U pTZ19U       supported result gel filtration G-3000 resin,
(United States Biochemical), yielding pLl-18U, pLl-19U,          resulted BTFlY-dependent transcription activity
pL2-18U, pL2-19U, used generate single-        fractions contained 27-kDa polypeptide
stranded DNA. Approximately 1.3 kb insert            (Fig. 1C).  BTF1Y behaved monomer sequenced plasmid, using probe primer       G-3000 chromatography conditions, activity pL1-18U pL2-18U DNAs. Additional primers            eluted apparent molecular mass 28 ± 5 kDa.
synthesized sequencing, yielded identical         Cloning Sequencing BTF1Y Gene. Transcription-
sequences pL1 pL2 (Fig. 2A).                             ally active BTF1Y fractions heparin-SPW HPLC
   Expression BTF1Y Protein HeLa Cells. synthetic      column fractionated SDS/PAGE electroblotted.
oligodeoxynucleotide 5'-TTCCTCATCGGCCATGGTG-                     situ lysine-C endoproteinase hydrolysis elec-
GAAAAGAATTCTCTTGATACACC-3' used gener-                    tro-blotted 27-kDa polypeptide, peptides purified
ate EcoRI site consensus Kozak sequence (23)         microsequenced. sets degenerate oligonucleotide
positions -10 -5  respect initiator codon)    probes synthesized used screening yeast BTF1Y sequence present pL2-18U, yielding plasmid          genomic library. clones, pL1 pL2, hybridized
pEV1. 1.1-kb EcoRI-BamHI fragment pEV1 contain-           oligonucleotide probes subcloned pTZ18U
ing complete BTF1Y open reading frame (ORF)              pTZ19U sequenced strands. 1265-bp
inserted EcoRI-BamHI sites expression vector     sequence present pL1 pL2 (Fig. 2A) contained pSG513  derivative pSG5 (24) larger polylinker],     720-nucleotide ORF (positions 375-1094) translated giving rise pEV2. HeLa cells ( 3 x 106 150-mm tissue      polypeptide 240 residues, calculated size 27,003
culture dish; 50  confluence) transfected 20 ,g     Da, agreement expected molecular mass pEV2  pSG513 control) DNA described (13).         BTF1Y  . expected, sequenced pep-
hours later, cell extracts (0.8 ml; 1.2 mg/ml)        tides, preceded lysine residue, prepared (3) dishes pEV2- pSG513-transfected      translated sequence (starting residues 16, 84, 219,
HeLa cells loaded 500-,ul heparin-Ultrogel columns        underlined Fig. 2A). search EMBL (release 18)
equilibrated buffer DB containing 0.1 M KCI  .      Swiss-Prot (release 10) data bases, significant homol-
Proteins eluted buffer DB containing KCI 50 mM      ogy BTF1Y DNA sequence steps (Fig. 3 B). dialysis buffer B          published DNA sequences deduced protein
containing 80 mM KCI, 350-450 mM KCI fractions          sequence known proteins. heparin-Ultrogel columns pooled, aliquots (450         single TATA box-like sequence (5'-
,ul) loaded 400-pl DEAE-Sephacel columns equil-        ATATAAAA-3', starting position 112 Fig. 2A), ibrated buffer B containing 80 mM KCL. columns       significant homology eukaryotic regulatory
washed twice buffer B containing 80 mM KCI (FT-2        sequences compiled Wingender (27) FT-3 Fig. 3 C D), absorbed proteins          374 bp immediately 5' initiation codon. Interestingly,
eluted stepwise KCl.                                        internal homology search revealed presence    Disruption BTF1Y Gene. 2.4-kb EcoRI-EcoRI          homologous domains blocks perfect
fragment pL2 containing complete BTF1Y ORF            homology (QNIV, positions 68 158; LIF-SGK-V-TGAK,
              Biochemistry: Cavallini               et al.                                                     Proc. Natl. Acad. Sci. USA 86 (1989)                9805

        \CE)                 CD           ®&fi Heparin
                                                   C    Fractions
                                                                    -
                                                                        Ultrogel
                             0
                                                                                               1                                                   TAGATCTLACTCAT
                                                                    0      D e0               15   CTCTTTACGTATTTTaaTTG TGALGCCGTAAATAGTTATC TTCCAAGTTTCTCTTACGCG
                                                                                              75   AGCTTTTTGGGAAAGAAA AAATTTGAAGaTCTACA MCATGGCTTCAGGAT
                                                                                             135   TACTAATGACTTTTTTT CC TTGATAGGTATTCTTGATGG TAAGAGTAAACAAGGGACGT
                                                            l           *EIt L               195   GAALATTACAGTAGTTACTG TT TTTGGCTATLAGAT CGGGGGAAGATAACACATA
                                                                                             255   AGAALTAAAACGACTACTAG TTAGACTGCTCTGCGGAAGA aGCAaGGaAGTAAaGGCTGC
                   M
                        cnc                                                        -309      315   ATTTTATTTTTCTTTTCTAG TCCAACATaaCGGTGTAT CG         CTTTAATT
                                              L:
                                                                                    nt       375   ATG GCC GAT GAG GAa CGT TTA aAG GaG TTT AaA GAG GCA AAC aAG ATA
                                                                                               1   MET ala Asp Glu Glu Arg Lou Lys Glu Phe Lys Glu ala asn Lys 
         67-                                                                                 423   GTG TTT GAT CCa AAT ACC AGa CAa GTA TGG GAL ALC CAG ALT CGA GAT
                                                                                              17   Val Ph Pro anTi Lrp Gin Val Tip Gl ALn Gln asn Arg Lap
         43                                                                                471   GGT ACA AAa CCa GCA ACT ACT TTC CAG AGT GAA GAG GAC ATA AAA AGA
                                                                                              33   Gly Thr Lys Pro Ala Thr Thr Phe Gln Set Glu Glu Asp Ile Lys Arg

         30-
                  67-~~~~~~~~~~3                                                             519
                                                                                              49
                                                                                                   GCT GCC CCL GLA TCT GMA AL GAC ACC TCC GCC Aca TCA GGT ATT GTT
                                                                                                   Ala Ala Pro Glu Ser Glu Lys asp Thr Set Ala Thr Set Gly Ile Val
                                  t~~~~~~~~~~n
                                                                                             567   CCa ACA CTA CAL LAC ATT GTG GCA ACT GTG ACT TTG GGG TGC aGG TTA
                                                                                              65   Pro Thr Lou Gln LAn Ile Val A1a Thr Val Thr Lou Gly Cys Arg Lou
         20-       30-~~~                                                                    615   GAT CTG AL Aca GTT GCG CTA CaT GCC CGT aLT GCA GAL TAT AaC CCC
                                                   e                                          81    asp Lou Lys                             Ala Glu Ur Pro
                                                                                   -21       663   AaG CGT TTT GCT GCT GTC ATC ATG CGT aTT AGa GAG CCL AaA ACT ACA
                   20-~~~                                                                     97   Lya Arg Ph. Ala Ala Val Ile Mot Arg Ile Arg Glu Pro Lya Thr Thr
            14-                   t                ***                                       711   GCT TTA ATT TTT GCC TCA GGG AAR ATG GTT GTT ACC GGT GCL AAA AGT
                                                                                             113   Ala Lu Ile Phe Ala Ser Gly Lys Met Val Val Thr Gly Ala Lys Set
                  1 2 3 4 5 6 78                   1 2 3 4 5 6 7                             759   GAG GAT GAC TCA AAG CTG GCC AGT AGA Aa TAT GCA AGA ATT ATC CAL
                                                                                             129   Glu asp asp Ser Lys Lou Ala Sor Arg Lys Tyr Aa. arg Ile Gln
                                                                                             807   AAA ATC GGG T GCT GCT ALA TTC ACa GAC TTC LAL ATA CLA AaT ATT
                                                                                             145   Lys Ile Gly Phb Aa Ala Lys Pho Thr asp Ph. Lys Ile Gln asn Ile
        ©s                            G-3000 Fractions
                                                                                             855   GTC GGT TCG TGT GAC GTT AAA TTC CCT ATA CGT CTA GLA GGG TTA GCA
                                                                                             161   Val Gly Set Cys Lsp Val Lys Phb Pro Ile krg Lou Glu Gly Lou A1a
                         L 10 11 12 13 14 15 16 1718 19 20 21 22 23
                                                                                             903   TTC AGT CAT GGT ACT TTC TCC TCC TAT GAG CCa GAa TTG TTT CCT GGT
        [3W                                                                                  177   Phe Ser Gly Thr Ph. Ser Ser Tyr Glu Pro Glu Lou Phe Pro Gly
                                                                                             951   TTG ATC TAT aGA ATG GTG AG CCG ALA ATT GTG TTG TTA ATT TTT GTT
                                                                                             193   Lou Ile Tyr Arg Mat Val Lys Pro Lys Ile Val Lou Lou Ile Pb. Val
                  9-
                        Io                q                                                  999   TCL GGA ALG ATT GTT CTT ACT GGT GCA aLG CAa AGG GAa GLA ATT TAC
                                                                                             209   Ser Gly Lys Ile Val Lou Thr Gly Ala Lys Gin kip G Glu  Ty
                                                                                            1047   CAa GCT TTT GLA GCT ATA TAC CCT GTG CTa AGT GaA TTT AGA Aaa ATG
                                                                                             225      Cgpj      j Ala Ile Tyr Pro Val Lou Ser Glu Phe Arg Lys MET
                                                                                            1095   TGATGGGG GTAGACG AG G            GTTTCT ATTTGTTCCATTTTCTCAaT
                                                                                            1155   TATTAATGGTCCTC AAAGa       aa GGAG AGTALTTGTATATCAALCG
                                                                                            1215   GTTTTTATAGTATATTCTT CTTATTCTATATTTATATAT CATGTTTTAT

        c      43-

        0




                  30-                                                                                     50         60       70        80         90       100
                                                                                                   SVD IKRLPESED TSATSGIVTLQNIVATVTLGCLLDLKTVL-BLRNLZYNPKR
                                                                                                   SKTLASYARIIQKI ALfTDrKIQNIVGSCDVKFPIRLZGLAFSBGTFSSYPEZLFPG
                                                                                                         140        150      160       170       180       190
                                                                                                         110        120      130
                  20-                                                                              VIJIREtPKTAJLIrAGnS4vvTGaKsEDD
                                                                          
                                                                                                   LIYWN KIVLLIrVSGIVLTGUQRU
                                                                                                        200        210      220
   FIG. 1. Purification BTF1Y.   SDS/PAGE analysis pu-
rification. Samples ("10 ,ug protein lanes 2-5; -1 ,ug lanes                        FIG. 2.   Sequence BTF1Y gene. 1265-base se-
6-8) chromatographic fractions electrophoresed                            quence encompassing 720-base ORF shown. BTF1Y
silver-stained. Arrowhead, BTF1Y polypeptide (27 kDa). Lane M,                            peptides microsequenced underlined, putative
markers [molecular masses (kDa) left]. (B) BTF1Y transcription                         5' flanking TATA box. (B) Sequence homology BTF1Y DNA-binding activities heparin-Ultrogel fractions. Tran-                       protein. Amino acids marked relative position 1 ORF.
scription activity (Upper) measured run RNA synthesis                          Identical amino acids indicated dots, single dots 3 jul heparin-Ultrogel fraction (250-500 mM KCI, lanes                       indicate similar amino acids. overall homology 33  2-7 indicated), Ad2MLP template, HeLa vitro                                identical amino acids taken account (standard deviations
transcription lacking BTF1 factor (17). specific                           control mean 5).
Ad2MLP run transcript 309 nucleotides (nt) long. Lane C
(control), fraction added. DNA-binding activity (Lower)                            positions 114 205; Fig. 2B).  hydro-
detected DNase footprinting coding strand                              pathicity profiles 42-131 132-222 sequences Ad2MLP sequence pM97 (26). Lanes 2-7, 6 fmol (""15,000 cpm) 294-base-pair (bp) BamHI-Sac II fragment pM97 (5'-                            similar (data shown).
end-labeled BamHI site) 3 ,/l indicated heparin-                           Transcriptional Activity BTF1Y Gene Expressed Ultrogel fractions incubated 20 ul 4 mM Tris HCI, pH                           HeLa Cells. demonstrate cloned gene encodes 8.0/60 mM KCI/5 mM MgCI2/17.4  glycerol/0.1  Brij-58                                 functional BTF1Y protein, cloned ORF expressed poly(dG dC) 4 ng/,l; 40-min preincubation 20°C, 25 ng                       HeLa cells. Cells transfected parental DNase added 30 sec. phenol/chloroform extrac-                          expression vector pSG513 (used control) pEV2
tion, DNA electrophoresed described (26). Lane 1, naked                            (pSG513 containing BTF1Y ORF). cell extracts
DNA. Protected region (-21 -31) indicated; hatched area                             prepared, loaded heparin-Ultrogel column,
corresponds TATAAA sequence. (C) G-3000 gel filtration.                         eluted 50 mM KCI steps (Fig. 3). Aliquots aliquot (500 ,ul) active fractions second heparin-Ultrogel                  assayed BTF1Y activity vitro HeLa cell-based
column fractionated G3000-SW HPLC column (0.75 x 60
cm; flow rate, 0.3 ml/min; 0.6-ml fractions). Aliquots (8 ,ul) fractions               transcription lacking BTF1  . expected
10-23 tested transcription activity (Upper) described                      Fig. 1B), BTF1-like activity B. Aliquots fractions (100 jl) analyzed SDS/14                        fractions derived pEV2-transfected cells (350-450 mM
PAGE silver staining (Lower). Arrowhead, 27-kDa polypeptide.                         KCI, Fig. 3B). identically prepared extracts HeLa
Lanes L, aliquots loaded heparin-Ultrogel fraction.                                cells transfected parental vector pSG513, 
 9806         Biochemistry: Cavallini et al.                                                                   Proc. Natl. Acad. Sci. USA 86        (1989)

                               pSG513         '                     pEV2                                     pDIS
                                KCI(mM)                               KCI(mM)                                                        Kb
                                                                                                                                             0)<m 
                                             ~~~~~-CJI~~~~~~~~~~~~~~~~
                                                        10000000000
         c      2                             1-1o0LO0LO0O0Lo00
               .LL                            LLL_U- CM CLm O t OL OC
                                                                                                                                     2.4 -             J
   
   .l)
                                                                        0 -  .,*        -309
                                                                                          nt

  D                                KCI(mM)    ©                        KC1(mM)                                                       -~~~~ ~~~~~~~~~~~~~~~~
                                                                                                                                        0...
                    _c,CVM                               _- CM Ml
                              10000000
                                                        F FI~ UpsIOUNN m
                                                                    oOOOO000
                                                                                   O
         -C L       ILI-T        CNNMCOt
  w
  <       ii
                    4.<:8i'':-     e~!        0 "                                -309
                                                  -.:
                                                               . 
                                                                                         nt
                                                                                                  FIG. 4. Disruption BTF1Y gene.   Structure pDIS
   FIG. 3. Transcription activity BTF1Y protein produced                             plasmid used BTF1Y gene disruption. P; polylinker pTZ19U,
HeLa cells. expression vector pEV2, containing BTF1Y                                   Sal  Xba Sma sites destroyed; E, B,
ORF, parental expression vectors pSG513  control)                            H, X, N, EcoRI, BamHI, HindIll, Xba  Nco restriction
transfected HeLa cells. cell extracts prepared,                            sites, respectively. Drawing scale. BTF1Y URA3 genes
                                                                                               transcribed leftward rightward, respectively. (B) Southern
proteins chromatographed heparin-Ultrogel columns,                                 blot Ura' transformants. Lanes C1-C4, DNA (12 ,ug) aliquots (5 jul) recovered fractions assayed BTF1                              transformant digested EcoRI, electrophoresed agar-
transcription activity run assay Fig. 1. specific                         ose gel, hybridized 2.4-kb EcoRl fragment pL2; lanes
309-nucleotide (nt) run transcript present incubations                              B, EcoRI-digested genomic DNA (12 ,4g) nontrans-
containing 350-450 mM KCl fractions derived pEV2-                                 formed Ura- diploid clones; lane pL2; 15 ng EcoRI-digested pL2
transfected cells (B), corresponding control                           plasmid DNA (nondisrupted BTF1Y gene); pDIS, 15 ng EcoRI-
pSG513-transfected cells  . active pEV2 fractions pooled                            digested pDIS plasmid DNA (disrupted BTF1Y gene). Arrows
 corresponding pSG513 fractions) chromato-                                indicate EcoRI fragment (2.4 kb) nondisrupted allele graphed DEAE-Sephacel columns. BTF1Y activity                                       EcoRI fragment (3.6 kb) disrupted allele. (C) Viable spores (5-pl aliquots assayed) flow (FT) fractions                          tetrad analysis. Sporulation Ural transformants corresponding pEV2-transfected cells (D), cor-                             induced asci dissected. ascus (arrows) responding control cells (C). Lane (-) C; addition                          spores placed rich medium (YPED) indicated bars
chromatographic aliquots; lane C C; control run tran-                             left. case, spores germinated  text).
scription 5-pLI aliquot HEPO.5 fraction  BTF1Y
purification Materials Methods); lane L C D; 5-pl
aliquots pooled 350-450 mM KCI fractions heparin-                              4C). Furthermore, colonies Ura-, indicating Ultrogel columns displayed B, respectively, assayed                               did contain URA3-disrupted BTF1Y allele. Similar
run transcription.                                                                         results obtained S. cerevisiae strain YNN290 (25)
                                                                                               (data shown). appears,  BTF1Y gene
dogenous BTF1 activity low detected (Fig. 3A).                                    single-copy essential gene. active fractions "pEV2" heparin-Ultrogel equivalent fractions "pSG513" heparin-Ultrogel                                                                DISCUSSION loaded DEAE-Sephacel columns step-eluted
aliquots tested BTF1 activity. Aliquots                                        yeast protein replace human HeLa cell
flow fractions (FT2 FT3) derived pEV2-                                        TATA box factor BTF1 (TFIID) vitro reconstituted
transfected HeLa cells active (Fig. 3D),                                       transcription (17, 18) purified apparent
BTF1 activity corresponding fractions                                         homogeneity. purif